Strategic Timeline

Ojala Healthcare Group Strategic Timeline

Our 5-year strategic plan for building a leading infusion therapy platform in South Florida

Strategic Approach

Ojala Healthcare Group is executing a disciplined rollup strategy in the fragmented South Florida infusion therapy market. We target high-quality providers at 3-5x EBITDA multiples, implement operational improvements through our systematic 100-day integration plan, and position the platform for exit at 7-10x EBITDA multiples within a 3-5 year timeframe.

Target Acquisitions

8-12

Infusion Centers

Acquisition Multiple

3-5x

EBITDA

Target Exit Multiple

7-10x

EBITDA

Target IRR

25-35%

For Investors

Year 1: Foundation

Platform Establishment

  • Complete initial capital raise
  • Acquire 2-3 initial infusion centers
  • Implement standardized clinical protocols
  • Establish centralized administrative functions
  • Develop proprietary integration playbook
  • Build executive leadership team

Year 2: Growth

Operational Optimization

  • Acquire 2-3 additional infusion centers
  • Implement revenue cycle management improvements
  • Optimize payor contracts across platform
  • Establish centralized purchasing program
  • Begin quarterly distributions to investors
  • Achieve 15-20% EBITDA margin improvement

Year 3: Expansion

Market Penetration

  • Acquire 2-3 additional infusion centers
  • Expand service offerings across platform
  • Implement proprietary patient management system
  • Develop strategic relationships with health systems
  • Enhance referral source management program
  • Achieve platform-wide operational synergies

Year 4: Refinement

Strategic Positioning

  • Complete final 1-2 acquisitions
  • Optimize capital structure
  • Enhance financial reporting systems
  • Develop exit marketing materials
  • Engage investment banker for exit planning
  • Implement final operational improvements

Year 5: Exit

Value Realization

  • Market platform to strategic acquirers
  • Negotiate optimal transaction structure
  • Complete due diligence process
  • Execute definitive agreements
  • Close transaction at 7-10x EBITDA multiple
  • Distribute proceeds to investors

Key Value Drivers

Our strategic timeline is designed to create value through multiple mechanisms:

  • Multiple Expansion: Acquiring at 3-5x EBITDA and exiting at 7-10x EBITDA
  • Operational Improvements: Implementing our 100-day integration plan to capture immediate synergies
  • Scale Benefits: Leveraging increased size for improved payor contracts and purchasing power
  • Strategic Positioning: Creating a dominant regional platform attractive to strategic acquirers
View Acquisition Process
Investor Information
Contact Us
Scroll to top